In8bio earnings were -$27.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest INAB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.6M, down 9.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INAB reported annual earnings of -$30.4M, with 1.4% growth. The next INAB earnings date is Aug 7, 2025.
In8bio (NASDAQ: INAB) reported Q1 2025 earnings per share (EPS) of -$2.10, up 65% year over year. Total INAB earnings for the quarter were -$5.55 million. In the same quarter last year, In8bio's earnings per share (EPS) was -$6.00.
The next INAB earnings call is Invalid Date. Add INAB to your watchlist to be reminded of In8bio's next earnings date.
Is In8bio profitable or losing money?
As of the last In8bio earnings report, In8bio is currently losing money. In8bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$27.43 million, a 11.66% decrease year over year.
What was INAB's earnings growth in the past year?
As of In8bio's earnings date in Q3 2025, In8bio's earnings has grown year over year. INAB earnings in the past year totalled -$27.43 million.
What are In8bio's earnings expectations?
The current EPS estimate for In8bio's earnings report in Invalid Date is -$0.06.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.